nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—forelimb zeugopod—systemic scleroderma	0.17	0.314	CbGeAlD
Amifostine—ALPPL2—skeletal joint—systemic scleroderma	0.113	0.208	CbGeAlD
Amifostine—ALPPL2—artery—systemic scleroderma	0.0472	0.0869	CbGeAlD
Amifostine—ALPPL2—endothelium—systemic scleroderma	0.0399	0.0734	CbGeAlD
Amifostine—ALPPL2—blood vessel—systemic scleroderma	0.0368	0.0677	CbGeAlD
Amifostine—ENPP1—connective tissue—systemic scleroderma	0.0196	0.036	CbGeAlD
Amifostine—ALPPL2—connective tissue—systemic scleroderma	0.0188	0.0347	CbGeAlD
Amifostine—ENPP1—skin of body—systemic scleroderma	0.0177	0.0325	CbGeAlD
Amifostine—ALPPL2—skin of body—systemic scleroderma	0.017	0.0314	CbGeAlD
Amifostine—ALPPL2—digestive system—systemic scleroderma	0.0136	0.0251	CbGeAlD
Amifostine—ENPP1—tendon—systemic scleroderma	0.0134	0.0248	CbGeAlD
Amifostine—ALPL—lung—systemic scleroderma	0.0128	0.0237	CbGeAlD
Amifostine—ENPP1—lung—systemic scleroderma	0.0118	0.0217	CbGeAlD
Amifostine—ALPPL2—lung—systemic scleroderma	0.0114	0.0209	CbGeAlD
Amifostine—ENPP1—Dexamethasone—Mometasone—systemic scleroderma	0.00592	0.324	CbGdCrCtD
Amifostine—ENPP1—Betamethasone—Mometasone—systemic scleroderma	0.00592	0.324	CbGdCrCtD
Amifostine—Hypocalcaemia—Mycophenolate mofetil—systemic scleroderma	0.00348	0.00792	CcSEcCtD
Amifostine—ENPP1—Dexamethasone—Prednisone—systemic scleroderma	0.00323	0.176	CbGdCrCtD
Amifostine—ENPP1—Betamethasone—Prednisone—systemic scleroderma	0.00323	0.176	CbGdCrCtD
Amifostine—Hiccups—Mycophenolate mofetil—systemic scleroderma	0.00318	0.00725	CcSEcCtD
Amifostine—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.00317	0.00723	CcSEcCtD
Amifostine—Flushing—Pentoxifylline—systemic scleroderma	0.00315	0.00719	CcSEcCtD
Amifostine—Atrial fibrillation—Mycophenolic acid—systemic scleroderma	0.00309	0.00704	CcSEcCtD
Amifostine—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00304	0.00692	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.00293	0.00667	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00284	0.00648	CcSEcCtD
Amifostine—Renal failure—Captopril—systemic scleroderma	0.00282	0.00643	CcSEcCtD
Amifostine—Cardiac arrest—Mycophenolic acid—systemic scleroderma	0.00278	0.00634	CcSEcCtD
Amifostine—Atrial fibrillation—Lisinopril—systemic scleroderma	0.00278	0.00634	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.00276	0.0063	CcSEcCtD
Amifostine—Ill-defined disorder—Pentoxifylline—systemic scleroderma	0.00275	0.00626	CcSEcCtD
Amifostine—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.00272	0.00621	CcSEcCtD
Amifostine—Malaise—Pentoxifylline—systemic scleroderma	0.00267	0.00608	CcSEcCtD
Amifostine—Convulsion—Pentoxifylline—systemic scleroderma	0.00256	0.00584	CcSEcCtD
Amifostine—Hypertension—Pentoxifylline—systemic scleroderma	0.00255	0.00582	CcSEcCtD
Amifostine—Chest pain—Pentoxifylline—systemic scleroderma	0.00252	0.00574	CcSEcCtD
Amifostine—Cardiac arrest—Lisinopril—systemic scleroderma	0.00251	0.00571	CcSEcCtD
Amifostine—Discomfort—Pentoxifylline—systemic scleroderma	0.00249	0.00567	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.00248	0.00566	CcSEcCtD
Amifostine—Atrial fibrillation—Mycophenolate mofetil—systemic scleroderma	0.00244	0.00556	CcSEcCtD
Amifostine—Erythema multiforme—Captopril—systemic scleroderma	0.00244	0.00555	CcSEcCtD
Amifostine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00241	0.0055	CcSEcCtD
Amifostine—Flushing—Captopril—systemic scleroderma	0.00239	0.00545	CcSEcCtD
Amifostine—Shock—Pentoxifylline—systemic scleroderma	0.00238	0.00541	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.00237	0.00541	CcSEcCtD
Amifostine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00236	0.00537	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00234	0.00534	CcSEcCtD
Amifostine—Renal failure—Leflunomide—systemic scleroderma	0.00232	0.0053	CcSEcCtD
Amifostine—Hypotension—Pentoxifylline—systemic scleroderma	0.00226	0.00514	CcSEcCtD
Amifostine—Renal failure—Mycophenolic acid—systemic scleroderma	0.00222	0.00505	CcSEcCtD
Amifostine—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.0022	0.00501	CcSEcCtD
Amifostine—Chest pain—Mometasone—systemic scleroderma	0.00217	0.00495	CcSEcCtD
Amifostine—Hiccups—Prednisone—systemic scleroderma	0.00216	0.00492	CcSEcCtD
Amifostine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00215	0.00491	CcSEcCtD
Amifostine—Somnolence—Pentoxifylline—systemic scleroderma	0.00215	0.00489	CcSEcCtD
Amifostine—Apnoea—Methotrexate—systemic scleroderma	0.00213	0.00485	CcSEcCtD
Amifostine—Erythema multiforme—Azathioprine—systemic scleroderma	0.00213	0.00484	CcSEcCtD
Amifostine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00208	0.00475	CcSEcCtD
Amifostine—Ill-defined disorder—Captopril—systemic scleroderma	0.00208	0.00474	CcSEcCtD
Amifostine—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00206	0.0047	CcSEcCtD
Amifostine—Malaise—Captopril—systemic scleroderma	0.00202	0.00461	CcSEcCtD
Amifostine—Chills—Azathioprine—systemic scleroderma	0.00202	0.0046	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00201	0.00459	CcSEcCtD
Amifostine—Syncope—Captopril—systemic scleroderma	0.00201	0.00458	CcSEcCtD
Amifostine—Arrhythmia—Azathioprine—systemic scleroderma	0.00201	0.00458	CcSEcCtD
Amifostine—Erythema multiforme—Leflunomide—systemic scleroderma	0.00201	0.00457	CcSEcCtD
Amifostine—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.002	0.00456	CcSEcCtD
Amifostine—Renal failure—Lisinopril—systemic scleroderma	0.002	0.00455	CcSEcCtD
Amifostine—Myocardial infarction—Lisinopril—systemic scleroderma	0.00199	0.00454	CcSEcCtD
Amifostine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00199	0.00453	CcSEcCtD
Amifostine—Loss of consciousness—Captopril—systemic scleroderma	0.00197	0.00449	CcSEcCtD
Amifostine—Urticaria—Pentoxifylline—systemic scleroderma	0.00192	0.00437	CcSEcCtD
Amifostine—Chest pain—Captopril—systemic scleroderma	0.00191	0.00435	CcSEcCtD
Amifostine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00191	0.00435	CcSEcCtD
Amifostine—Chills—Leflunomide—systemic scleroderma	0.0019	0.00434	CcSEcCtD
Amifostine—Arrhythmia—Leflunomide—systemic scleroderma	0.0019	0.00432	CcSEcCtD
Amifostine—Discomfort—Captopril—systemic scleroderma	0.00189	0.0043	CcSEcCtD
Amifostine—Dyspnoea—Mometasone—systemic scleroderma	0.00186	0.00423	CcSEcCtD
Amifostine—Bradycardia—Lisinopril—systemic scleroderma	0.00186	0.00423	CcSEcCtD
Amifostine—Anaphylactic shock—Captopril—systemic scleroderma	0.00183	0.00417	CcSEcCtD
Amifostine—Chills—Mycophenolic acid—systemic scleroderma	0.00182	0.00414	CcSEcCtD
Amifostine—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00182	0.00414	CcSEcCtD
Amifostine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00181	0.00412	CcSEcCtD
Amifostine—Shock—Captopril—systemic scleroderma	0.0018	0.0041	CcSEcCtD
Amifostine—Tachycardia—Captopril—systemic scleroderma	0.00179	0.00407	CcSEcCtD
Amifostine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00178	0.00405	CcSEcCtD
Amifostine—Malaise—Azathioprine—systemic scleroderma	0.00176	0.00402	CcSEcCtD
Amifostine—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00176	0.004	CcSEcCtD
Amifostine—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00399	CcSEcCtD
Amifostine—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00398	CcSEcCtD
Amifostine—Erythema multiforme—Lisinopril—systemic scleroderma	0.00172	0.00393	CcSEcCtD
Amifostine—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00171	0.00391	CcSEcCtD
Amifostine—Hypotension—Captopril—systemic scleroderma	0.00171	0.0039	CcSEcCtD
Amifostine—Pruritus—Pentoxifylline—systemic scleroderma	0.00171	0.00389	CcSEcCtD
Amifostine—Flushing—Lisinopril—systemic scleroderma	0.00169	0.00386	CcSEcCtD
Amifostine—Malaise—Leflunomide—systemic scleroderma	0.00167	0.0038	CcSEcCtD
Amifostine—Body temperature increased—Mometasone—systemic scleroderma	0.00165	0.00375	CcSEcCtD
Amifostine—Discomfort—Azathioprine—systemic scleroderma	0.00165	0.00375	CcSEcCtD
Amifostine—Chills—Lisinopril—systemic scleroderma	0.00164	0.00373	CcSEcCtD
Amifostine—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00164	0.00373	CcSEcCtD
Amifostine—Dyspnoea—Captopril—systemic scleroderma	0.00163	0.00372	CcSEcCtD
Amifostine—Arrhythmia—Lisinopril—systemic scleroderma	0.00163	0.00371	CcSEcCtD
Amifostine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00371	CcSEcCtD
Amifostine—Somnolence—Captopril—systemic scleroderma	0.00163	0.00371	CcSEcCtD
Amifostine—Dizziness—Pentoxifylline—systemic scleroderma	0.0016	0.00364	CcSEcCtD
Amifostine—Hypertension—Leflunomide—systemic scleroderma	0.0016	0.00364	CcSEcCtD
Amifostine—Malaise—Mycophenolic acid—systemic scleroderma	0.00159	0.00362	CcSEcCtD
Amifostine—Syncope—Mycophenolic acid—systemic scleroderma	0.00158	0.0036	CcSEcCtD
Amifostine—Chest pain—Leflunomide—systemic scleroderma	0.00157	0.00359	CcSEcCtD
Amifostine—Discomfort—Leflunomide—systemic scleroderma	0.00155	0.00354	CcSEcCtD
Amifostine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00155	0.00353	CcSEcCtD
Amifostine—Vomiting—Pentoxifylline—systemic scleroderma	0.00154	0.0035	CcSEcCtD
Amifostine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00153	0.00348	CcSEcCtD
Amifostine—Rash—Pentoxifylline—systemic scleroderma	0.00152	0.00347	CcSEcCtD
Amifostine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00152	0.00347	CcSEcCtD
Amifostine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00152	0.00347	CcSEcCtD
Amifostine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00151	0.00344	CcSEcCtD
Amifostine—Feeling abnormal—Captopril—systemic scleroderma	0.00151	0.00344	CcSEcCtD
Amifostine—Chest pain—Mycophenolic acid—systemic scleroderma	0.0015	0.00342	CcSEcCtD
Amifostine—Hypotension—Azathioprine—systemic scleroderma	0.00149	0.0034	CcSEcCtD
Amifostine—Cardiac arrest—Prednisone—systemic scleroderma	0.00149	0.00339	CcSEcCtD
Amifostine—Discomfort—Mycophenolic acid—systemic scleroderma	0.00148	0.00338	CcSEcCtD
Amifostine—Pruritus—Mometasone—systemic scleroderma	0.00147	0.00336	CcSEcCtD
Amifostine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00147	0.00336	CcSEcCtD
Amifostine—Tachycardia—Leflunomide—systemic scleroderma	0.00147	0.00335	CcSEcCtD
Amifostine—Body temperature increased—Captopril—systemic scleroderma	0.00145	0.0033	CcSEcCtD
Amifostine—Nausea—Pentoxifylline—systemic scleroderma	0.00143	0.00327	CcSEcCtD
Amifostine—Chills—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00327	CcSEcCtD
Amifostine—Malaise—Lisinopril—systemic scleroderma	0.00143	0.00326	CcSEcCtD
Amifostine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00325	CcSEcCtD
Amifostine—Syncope—Lisinopril—systemic scleroderma	0.00142	0.00325	CcSEcCtD
Amifostine—Shock—Mycophenolic acid—systemic scleroderma	0.00142	0.00323	CcSEcCtD
Amifostine—Hypotension—Leflunomide—systemic scleroderma	0.00141	0.00321	CcSEcCtD
Amifostine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.0014	0.0032	CcSEcCtD
Amifostine—Loss of consciousness—Lisinopril—systemic scleroderma	0.0014	0.00318	CcSEcCtD
Amifostine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00139	0.00316	CcSEcCtD
Amifostine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00135	0.00308	CcSEcCtD
Amifostine—Chest pain—Lisinopril—systemic scleroderma	0.00135	0.00308	CcSEcCtD
Amifostine—Dyspnoea—Leflunomide—systemic scleroderma	0.00134	0.00306	CcSEcCtD
Amifostine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00134	0.00306	CcSEcCtD
Amifostine—Discomfort—Lisinopril—systemic scleroderma	0.00134	0.00304	CcSEcCtD
Amifostine—Vomiting—Mometasone—systemic scleroderma	0.00132	0.00302	CcSEcCtD
Amifostine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00132	0.003	CcSEcCtD
Amifostine—Rash—Mometasone—systemic scleroderma	0.00131	0.00299	CcSEcCtD
Amifostine—Dermatitis—Mometasone—systemic scleroderma	0.00131	0.00299	CcSEcCtD
Amifostine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.0013	0.00295	CcSEcCtD
Amifostine—Pruritus—Captopril—systemic scleroderma	0.00129	0.00295	CcSEcCtD
Amifostine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00294	CcSEcCtD
Amifostine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00128	0.00292	CcSEcCtD
Amifostine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00128	0.00291	CcSEcCtD
Amifostine—Shock—Lisinopril—systemic scleroderma	0.00128	0.00291	CcSEcCtD
Amifostine—Tachycardia—Lisinopril—systemic scleroderma	0.00126	0.00288	CcSEcCtD
Amifostine—Body temperature increased—Azathioprine—systemic scleroderma	0.00126	0.00288	CcSEcCtD
Amifostine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00286	CcSEcCtD
Amifostine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00284	CcSEcCtD
Amifostine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00124	0.00283	CcSEcCtD
Amifostine—Nausea—Mometasone—systemic scleroderma	0.00124	0.00282	CcSEcCtD
Amifostine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00279	CcSEcCtD
Amifostine—Hypotension—Lisinopril—systemic scleroderma	0.00121	0.00276	CcSEcCtD
Amifostine—Dizziness—Captopril—systemic scleroderma	0.00121	0.00276	CcSEcCtD
Amifostine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00275	CcSEcCtD
Amifostine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00274	CcSEcCtD
Amifostine—Urticaria—Leflunomide—systemic scleroderma	0.0012	0.00273	CcSEcCtD
Amifostine—Body temperature increased—Leflunomide—systemic scleroderma	0.00119	0.00272	CcSEcCtD
Amifostine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00119	0.00271	CcSEcCtD
Amifostine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00119	0.0027	CcSEcCtD
Amifostine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00118	0.0027	CcSEcCtD
Amifostine—Myocardial infarction—Prednisone—systemic scleroderma	0.00118	0.0027	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00118	0.00269	CcSEcCtD
Amifostine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00118	0.00268	CcSEcCtD
Amifostine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00267	CcSEcCtD
Amifostine—Vomiting—Captopril—systemic scleroderma	0.00116	0.00265	CcSEcCtD
Amifostine—Dyspnoea—Lisinopril—systemic scleroderma	0.00116	0.00263	CcSEcCtD
Amifostine—Rash—Captopril—systemic scleroderma	0.00115	0.00263	CcSEcCtD
Amifostine—Dermatitis—Captopril—systemic scleroderma	0.00115	0.00263	CcSEcCtD
Amifostine—Somnolence—Lisinopril—systemic scleroderma	0.00115	0.00263	CcSEcCtD
Amifostine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00114	0.00259	CcSEcCtD
Amifostine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00259	CcSEcCtD
Amifostine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00255	CcSEcCtD
Amifostine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00111	0.00253	CcSEcCtD
Amifostine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00253	CcSEcCtD
Amifostine—Bradycardia—Prednisone—systemic scleroderma	0.0011	0.00251	CcSEcCtD
Amifostine—Nausea—Captopril—systemic scleroderma	0.00109	0.00248	CcSEcCtD
Amifostine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00107	0.00243	CcSEcCtD
Amifostine—Pruritus—Leflunomide—systemic scleroderma	0.00107	0.00243	CcSEcCtD
Amifostine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00242	CcSEcCtD
Amifostine—Dizziness—Azathioprine—systemic scleroderma	0.00106	0.00241	CcSEcCtD
Amifostine—Urticaria—Lisinopril—systemic scleroderma	0.00103	0.00235	CcSEcCtD
Amifostine—Body temperature increased—Lisinopril—systemic scleroderma	0.00102	0.00233	CcSEcCtD
Amifostine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00102	0.00232	CcSEcCtD
Amifostine—Vomiting—Azathioprine—systemic scleroderma	0.00102	0.00231	CcSEcCtD
Amifostine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00231	CcSEcCtD
Amifostine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00101	0.0023	CcSEcCtD
Amifostine—Rash—Azathioprine—systemic scleroderma	0.00101	0.00229	CcSEcCtD
Amifostine—Dermatitis—Azathioprine—systemic scleroderma	0.00101	0.00229	CcSEcCtD
Amifostine—Flushing—Prednisone—systemic scleroderma	0.00101	0.00229	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.001	0.00228	CcSEcCtD
Amifostine—Dizziness—Leflunomide—systemic scleroderma	0.000997	0.00227	CcSEcCtD
Amifostine—Renal failure—Methotrexate—systemic scleroderma	0.000992	0.00226	CcSEcCtD
Amifostine—Arrhythmia—Prednisone—systemic scleroderma	0.000968	0.00221	CcSEcCtD
Amifostine—Vomiting—Leflunomide—systemic scleroderma	0.000959	0.00219	CcSEcCtD
Amifostine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000955	0.00218	CcSEcCtD
Amifostine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000952	0.00217	CcSEcCtD
Amifostine—Rash—Leflunomide—systemic scleroderma	0.000951	0.00217	CcSEcCtD
Amifostine—Dermatitis—Leflunomide—systemic scleroderma	0.00095	0.00217	CcSEcCtD
Amifostine—Nausea—Azathioprine—systemic scleroderma	0.000949	0.00216	CcSEcCtD
Amifostine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000936	0.00213	CcSEcCtD
Amifostine—Pruritus—Lisinopril—systemic scleroderma	0.000917	0.00209	CcSEcCtD
Amifostine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000915	0.00208	CcSEcCtD
Amifostine—Rash—Mycophenolic acid—systemic scleroderma	0.000907	0.00207	CcSEcCtD
Amifostine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000906	0.00207	CcSEcCtD
Amifostine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000902	0.00206	CcSEcCtD
Amifostine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000898	0.00205	CcSEcCtD
Amifostine—Nausea—Leflunomide—systemic scleroderma	0.000896	0.00204	CcSEcCtD
Amifostine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000875	0.00199	CcSEcCtD
Amifostine—Dizziness—Lisinopril—systemic scleroderma	0.000857	0.00195	CcSEcCtD
Amifostine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000856	0.00195	CcSEcCtD
Amifostine—Nausea—Mycophenolic acid—systemic scleroderma	0.000855	0.00195	CcSEcCtD
Amifostine—Malaise—Prednisone—systemic scleroderma	0.000851	0.00194	CcSEcCtD
Amifostine—Syncope—Prednisone—systemic scleroderma	0.000846	0.00193	CcSEcCtD
Amifostine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000837	0.00191	CcSEcCtD
Amifostine—Loss of consciousness—Prednisone—systemic scleroderma	0.000829	0.00189	CcSEcCtD
Amifostine—Vomiting—Lisinopril—systemic scleroderma	0.000824	0.00188	CcSEcCtD
Amifostine—Rash—Lisinopril—systemic scleroderma	0.000817	0.00186	CcSEcCtD
Amifostine—Convulsion—Prednisone—systemic scleroderma	0.000817	0.00186	CcSEcCtD
Amifostine—Dermatitis—Lisinopril—systemic scleroderma	0.000816	0.00186	CcSEcCtD
Amifostine—Hypertension—Prednisone—systemic scleroderma	0.000814	0.00186	CcSEcCtD
Amifostine—Chills—Methotrexate—systemic scleroderma	0.000812	0.00185	CcSEcCtD
Amifostine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000803	0.00183	CcSEcCtD
Amifostine—Discomfort—Prednisone—systemic scleroderma	0.000793	0.00181	CcSEcCtD
Amifostine—Nausea—Lisinopril—systemic scleroderma	0.00077	0.00175	CcSEcCtD
Amifostine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00077	0.00175	CcSEcCtD
Amifostine—Shock—Prednisone—systemic scleroderma	0.000757	0.00173	CcSEcCtD
Amifostine—Tachycardia—Prednisone—systemic scleroderma	0.000751	0.00171	CcSEcCtD
Amifostine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000751	0.00171	CcSEcCtD
Amifostine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000731	0.00167	CcSEcCtD
Amifostine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00165	CcSEcCtD
Amifostine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000716	0.00163	CcSEcCtD
Amifostine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000715	0.00163	CcSEcCtD
Amifostine—Malaise—Methotrexate—systemic scleroderma	0.000711	0.00162	CcSEcCtD
Amifostine—Convulsion—Methotrexate—systemic scleroderma	0.000683	0.00156	CcSEcCtD
Amifostine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000675	0.00154	CcSEcCtD
Amifostine—Chest pain—Methotrexate—systemic scleroderma	0.000671	0.00153	CcSEcCtD
Amifostine—Discomfort—Methotrexate—systemic scleroderma	0.000663	0.00151	CcSEcCtD
Amifostine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000643	0.00147	CcSEcCtD
Amifostine—Feeling abnormal—Prednisone—systemic scleroderma	0.000634	0.00145	CcSEcCtD
Amifostine—Urticaria—Prednisone—systemic scleroderma	0.000612	0.00139	CcSEcCtD
Amifostine—Body temperature increased—Prednisone—systemic scleroderma	0.000609	0.00139	CcSEcCtD
Amifostine—Hypotension—Methotrexate—systemic scleroderma	0.000601	0.00137	CcSEcCtD
Amifostine—Dyspnoea—Methotrexate—systemic scleroderma	0.000574	0.00131	CcSEcCtD
Amifostine—Somnolence—Methotrexate—systemic scleroderma	0.000572	0.0013	CcSEcCtD
Amifostine—Hypersensitivity—Prednisone—systemic scleroderma	0.000567	0.00129	CcSEcCtD
Amifostine—Pruritus—Prednisone—systemic scleroderma	0.000545	0.00124	CcSEcCtD
Amifostine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00053	0.00121	CcSEcCtD
Amifostine—Urticaria—Methotrexate—systemic scleroderma	0.000511	0.00116	CcSEcCtD
Amifostine—Dizziness—Prednisone—systemic scleroderma	0.000509	0.00116	CcSEcCtD
Amifostine—Body temperature increased—Methotrexate—systemic scleroderma	0.000509	0.00116	CcSEcCtD
Amifostine—Vomiting—Prednisone—systemic scleroderma	0.000489	0.00112	CcSEcCtD
Amifostine—Rash—Prednisone—systemic scleroderma	0.000485	0.00111	CcSEcCtD
Amifostine—Dermatitis—Prednisone—systemic scleroderma	0.000485	0.0011	CcSEcCtD
Amifostine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000474	0.00108	CcSEcCtD
Amifostine—Nausea—Prednisone—systemic scleroderma	0.000457	0.00104	CcSEcCtD
Amifostine—Pruritus—Methotrexate—systemic scleroderma	0.000455	0.00104	CcSEcCtD
Amifostine—Dizziness—Methotrexate—systemic scleroderma	0.000425	0.000969	CcSEcCtD
Amifostine—Vomiting—Methotrexate—systemic scleroderma	0.000409	0.000932	CcSEcCtD
Amifostine—Rash—Methotrexate—systemic scleroderma	0.000406	0.000924	CcSEcCtD
Amifostine—Dermatitis—Methotrexate—systemic scleroderma	0.000405	0.000923	CcSEcCtD
Amifostine—Nausea—Methotrexate—systemic scleroderma	0.000382	0.000871	CcSEcCtD
